Physician profile
James Luckett
NPI 1114938495
$4,185.01
in general payments reported to CMS, 2019-2025
12 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,321 · 2020: $332 · 2021: $447 · 2022: $1,041 · 2023: $506 · 2024: $354 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,044.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,240.87 | 2019-2024 | Dovato, Cabenuva, Apretude |
| Janssen Products, Lp | $875.35 | 2019-2022 | |
| Gilead Sciences, INC. | $849.52 | 2019-2024 | |
| Emd Serono, INC. | $319.05 | 2022-2025 | Serostim, Serostim |
| Theratechnologies INC. | $309.30 | 2019-2025 | Trogarzo, Egrifta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $247.90 | 2019-2020 | |
| Napo Pharmaceuticals INC | $151.65 | 2019 | |
| Janssen Biotech, INC. | $99.73 | 2019-2021 | |
| Daiichi Sankyo INC. | $33.54 | 2019 | |
| Allergan, INC. | $29.99 | 2020 | |
| Merck Sharp & Dohme LLC | $15.77 | 2019 | |
| Tms Neurohealth Centers INC. | $12.34 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Luckett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.